))
BioChat #7: Harnessing the Immune System to Fight Cancer -- From ABclonal Technology
Manage episode 371124094 series 3464173
Content provided by ABclonal Technology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ABclonal Technology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
The immune system is now a key tool in developing personalized targeted therapies against many types of cancer. With an extensive background in immunology in the context of human disease, Philip Liu, Ph.D., joins BioChat to discuss a promising new drug against bladder cancer, and his unique career path towards this latest achievement.
Phil and Kin talk about our shared love of science, albeit with different career paths and methodologies to promote scientific breakthroughs, and advice for aspiring biomedical researchers. We also discuss the challenges in obtaining research funding and how the funding mechanism needs to adapt to continue attracting bright minds to academia to train the next generation of great scientists. Phil also asks what it is Kin actually does here!
Of course, we also talk about the exciting new IL-15-based therapy developed by Phil's company, ImmunityBio, as they have very promising results and are working towards clinical trials.
Please feel free to visit us at www.abclonal.com, read our blog posts here, including a look at the study of IL-15 as an immunotherapy, and check out our Doctor Beaker page for fun activities! You can also find all the ways to subscribe to our podcast via our BioChat page, which includes Apple Podcasts and Spotify.
24 episodes
Share
